Cognitive impairment among elderly coronary heart disease patients

M Ahto1, R Isoaho, H Puolijoki

  • 1Unit of General Practice, Oulu University Hospital and Department of Public Health Science and General Practice, University of Oulu, Finland.merja.ahto@utu.fi

Gerontology
|February 6, 1999
PubMed

Insights

Coronary heart disease (CHD) does not independently affect cognitive function in the elderly. However, complicated CHD in men may negatively impact cognitive abilities, particularly in orientation and language.

Area of Science:

  • Gerontology
  • Cardiology
  • Neurology

Background:

  • Coronary heart disease (CHD) and cognitive decline are prevalent in the elderly.
  • Cardiovascular diseases (CVDs) are linked to vascular dementia, but the relationship between CHD and general cognitive function in older adults requires further population-based study.

Purpose of the Study:

  • To investigate the association between coronary heart disease (CHD) and cognitive impairment in an elderly population.

Main Methods:

  • The Lieto study population included community-dwelling men and women aged 64 years and older.
  • Patients with CHD (defined by angina pectoris or myocardial infarction) were compared to age- and sex-matched controls without CHD.
  • Cognitive function was assessed using the Mini-Mental State Examination (MMSE).

Main Results:

  • No significant differences in overall cognitive functioning (total MMSE scores or subtest scores) were observed between elderly patients with CHD and controls.
  • In men, higher MMSE scores in orientation and language correlated with more severe chest pain.
  • Logistic regression indicated that cognitive impairment in men was associated with advanced age, cardiac glycoside use, and physical disability. In women, cognitive impairment was linked to advanced age and antipsychotic use.

Conclusions:

  • Coronary heart disease (CHD) generally shows no independent association with cognitive impairment in non-institutionalized, community-living elderly individuals.
  • A complex or severe form of CHD may negatively influence cognitive functioning in elderly men.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...